Sökning: onr:"swepub:oai:gup.ub.gu.se/324627" > CCNE1 and survival ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08668naa a2202089 4500 | |
001 | oai:gup.ub.gu.se/324627 | |
003 | SwePub | |
008 | 240910s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3246272 URI |
024 | 7 | a https://doi.org/10.1002/cncr.345822 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Kang, E. Y.4 aut |
245 | 1 0 | a CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study |
264 | c 2022-12-26 | |
264 | 1 | b Wiley,c 2023 |
520 | a Background: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification and CCNE1 overexpression with survival, but to date no large-scale, histotype-specific validation has been performed. The hypothesis was that high-level amplification of CCNE1 and CCNE1 overexpression, as well as a combination of the two, are linked to shorter overall survival in HGSC. Methods: Within the Ovarian Tumor Tissue Analysis consortium, amplification status and protein level in 3029 HGSC cases and mRNA expression in 2419 samples were investigated. Results: High-level amplification (>8 copies by chromogenic in situ hybridization) was found in 8.6% of HGSC and overexpression (>60% with at least 5% demonstrating strong intensity by immunohistochemistry) was found in 22.4%. CCNE1 high-level amplification and overexpression both were linked to shorter overall survival in multivariate survival analysis adjusted for age and stage, with hazard stratification by study (hazard ratio [HR], 1.26; 95% CI, 1.08-1.47, p = .034, and HR, 1.18; 95% CI, 1.05-1.32, p = .015, respectively). This was also true for cases with combined high-level amplification/overexpression (HR, 1.26; 95% CI, 1.09-1.47, p = .033). CCNE1 mRNA expression was not associated with overall survival (HR, 1.00 per 1-SD increase; 95% CI, 0.94-1.06; p = .58). CCNE1 high-level amplification is mutually exclusive with the presence of germline BRCA1/2 pathogenic variants and shows an inverse association to RB1 loss. Conclusion: This study provides large-scale validation that CCNE1 high-level amplification is associated with shorter survival, supporting its utility as a prognostic biomarker in HGSC. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a CCNE1 amplification | |
653 | a cyclin E1 expression | |
653 | a high-grade serous carcinoma | |
653 | a ovarian cancer | |
653 | a prognosis | |
700 | 1 | a Weir, A.4 aut |
700 | 1 | a Meagher, N. S.4 aut |
700 | 1 | a Farrington, K.4 aut |
700 | 1 | a Nelson, G. S.4 aut |
700 | 1 | a Ghatage, P.4 aut |
700 | 1 | a Lee, C. H.4 aut |
700 | 1 | a Riggan, M. J.4 aut |
700 | 1 | a Bolithon, A.4 aut |
700 | 1 | a Popovic, G.4 aut |
700 | 1 | a Leung, B.4 aut |
700 | 1 | a Tang, K.4 aut |
700 | 1 | a Lambie, N.4 aut |
700 | 1 | a Millstein, J.4 aut |
700 | 1 | a Alsop, J.4 aut |
700 | 1 | a Anglesio, M. S.4 aut |
700 | 1 | a Ataseven, B.4 aut |
700 | 1 | a Barlow, E.4 aut |
700 | 1 | a Beckmann, M. W.4 aut |
700 | 1 | a Berger, J.4 aut |
700 | 1 | a Bisinotto, C.4 aut |
700 | 1 | a Bosmuller, H.4 aut |
700 | 1 | a Boros, J.4 aut |
700 | 1 | a Brand, A. H.4 aut |
700 | 1 | a Brooks-Wilson, A.4 aut |
700 | 1 | a Brucker, S. Y.4 aut |
700 | 1 | a Carney, M. E.4 aut |
700 | 1 | a Casablanca, Y.4 aut |
700 | 1 | a Cazorla-Jimenez, A.4 aut |
700 | 1 | a Cohen, P. A.4 aut |
700 | 1 | a Conrads, T. P.4 aut |
700 | 1 | a Cook, L. S.4 aut |
700 | 1 | a Coulson, P.4 aut |
700 | 1 | a Courtney-Brooks, M.4 aut |
700 | 1 | a Cramer, D. W.4 aut |
700 | 1 | a Crowe, P.4 aut |
700 | 1 | a Cunningham, J. M.4 aut |
700 | 1 | a Cybulski, C.4 aut |
700 | 1 | a Darcy, K. M.4 aut |
700 | 1 | a El-Bahrawy, M. A.4 aut |
700 | 1 | a Elishaev, E.4 aut |
700 | 1 | a Erber, R.4 aut |
700 | 1 | a Farrell, R.4 aut |
700 | 1 | a Fereday, S.4 aut |
700 | 1 | a Fischer, A.4 aut |
700 | 1 | a Garcia, M. J.4 aut |
700 | 1 | a Gayther, S. A.4 aut |
700 | 1 | a Gentry-Maharaj, A.4 aut |
700 | 1 | a Gilks, C. B.4 aut |
700 | 1 | a Grube, M.4 aut |
700 | 1 | a Harnett, P. R.4 aut |
700 | 1 | a Harrington, S. P.4 aut |
700 | 1 | a Harter, P.4 aut |
700 | 1 | a Hartmann, A.4 aut |
700 | 1 | a Hecht, J. L.4 aut |
700 | 1 | a Heikaus, S.4 aut |
700 | 1 | a Hein, A.4 aut |
700 | 1 | a Heitz, F.4 aut |
700 | 1 | a Hendley, J.4 aut |
700 | 1 | a Hernandez, B. Y.4 aut |
700 | 1 | a Polo, S. H.4 aut |
700 | 1 | a Heublein, S.4 aut |
700 | 1 | a Hirasawa, A.4 aut |
700 | 1 | a Hogdall, E.4 aut |
700 | 1 | a Hogdall, C. K.4 aut |
700 | 1 | a Horlings, H. M.4 aut |
700 | 1 | a Huntsman, D. G.4 aut |
700 | 1 | a Huzarski, T.4 aut |
700 | 1 | a Jewell, A.4 aut |
700 | 1 | a Jimenez-Linan, M.4 aut |
700 | 1 | a Jones, M. E.4 aut |
700 | 1 | a Kaufmann, S. H.4 aut |
700 | 1 | a Kennedy, C. J.4 aut |
700 | 1 | a Khabele, D.4 aut |
700 | 1 | a Kommoss, F. K. F.4 aut |
700 | 1 | a Kruitwagen, Rfpm4 aut |
700 | 1 | a Lambrechts, D.4 aut |
700 | 1 | a Le, N. D.4 aut |
700 | 1 | a Lener, M.4 aut |
700 | 1 | a Lester, J.4 aut |
700 | 1 | a Leung, Y.4 aut |
700 | 1 | a Linder, Annau Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology4 aut0 (Swepub:gu)xliana |
700 | 1 | a Loverix, L.4 aut |
700 | 1 | a Lubinski, J.4 aut |
700 | 1 | a Madan, R.4 aut |
700 | 1 | a Maxwell, G. L.4 aut |
700 | 1 | a Modugno, F.4 aut |
700 | 1 | a Neuhausen, S. L.4 aut |
700 | 1 | a Olawaiye, A.4 aut |
700 | 1 | a Olbrecht, S.4 aut |
700 | 1 | a Orsulic, S.4 aut |
700 | 1 | a Palacios, J.4 aut |
700 | 1 | a Pearce, C. L.4 aut |
700 | 1 | a Pike, M. C.4 aut |
700 | 1 | a Quinn, C. M.4 aut |
700 | 1 | a Mohan, G. R.4 aut |
700 | 1 | a Rodriguez-Antona, C.4 aut |
700 | 1 | a Ruebner, M.4 aut |
700 | 1 | a Ryan, A.4 aut |
700 | 1 | a Salfinger, S. G.4 aut |
700 | 1 | a Sasamoto, N.4 aut |
700 | 1 | a Schildkraut, J. M.4 aut |
700 | 1 | a Schoemaker, M. J.4 aut |
700 | 1 | a Shah, M.4 aut |
700 | 1 | a Sharma, R.4 aut |
700 | 1 | a Shvetsov, Y. B.4 aut |
700 | 1 | a Singh, N.4 aut |
700 | 1 | a Sonke, G. S.4 aut |
700 | 1 | a Steele, L.4 aut |
700 | 1 | a Stewart, C. J. R.4 aut |
700 | 1 | a Sundfeldt, Karin,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology4 aut0 (Swepub:gu)xsukar |
700 | 1 | a Swerdlow, A. J.4 aut |
700 | 1 | a Talhouk, A.4 aut |
700 | 1 | a Tan, A.4 aut |
700 | 1 | a Taylor, S. E.4 aut |
700 | 1 | a Terry, K. L.4 aut |
700 | 1 | a Toloczko, A.4 aut |
700 | 1 | a Traficante, N.4 aut |
700 | 1 | a Van de Vijver, K. K.4 aut |
700 | 1 | a van der Aa, M. A.4 aut |
700 | 1 | a Van Gorp, T.4 aut |
700 | 1 | a Van Nieuwenhuysen, E.4 aut |
700 | 1 | a Van-Wagensveld, L.4 aut |
700 | 1 | a Vergote, I.4 aut |
700 | 1 | a Vierkant, R. A.4 aut |
700 | 1 | a Wang, C.4 aut |
700 | 1 | a Wilkens, L. R.4 aut |
700 | 1 | a Winham, S. J.4 aut |
700 | 1 | a Wu, A. H.4 aut |
700 | 1 | a Benitez, J.4 aut |
700 | 1 | a Berchuck, A.4 aut |
700 | 1 | a Dos Reis, F. J. C.4 aut |
700 | 1 | a DeFazio, A.4 aut |
700 | 1 | a Fasching, P. A.4 aut |
700 | 1 | a Goode, E. L.4 aut |
700 | 1 | a Goodman, M. T.4 aut |
700 | 1 | a Gronwald, J.4 aut |
700 | 1 | a Karlan, B. Y.4 aut |
700 | 1 | a Kommoss, S.4 aut |
700 | 1 | a Menon, U.4 aut |
700 | 1 | a Sinn, H. P.4 aut |
700 | 1 | a Staebler, A.4 aut |
700 | 1 | a Brenton, J. D.4 aut |
700 | 1 | a Bowtell, D. D.4 aut |
700 | 1 | a Pharoah, P. D. P.4 aut |
700 | 1 | a Ramus, S. J.4 aut |
700 | 1 | a Kobel, M.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi4 org |
773 | 0 | t Cancerd : Wileyg 129:5, s. 697-713q 129:5<697-713x 0008-543Xx 1097-0142 |
856 | 4 8 | u https://gup.ub.gu.se/publication/324627 |
856 | 4 8 | u https://doi.org/10.1002/cncr.34582 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy